Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

BLCO

Bausch plus Lomb (BLCO)

Bausch plus Lomb Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:BLCO
FechaHoraFuenteTítuloSímboloCompañía
03/03/202515:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
19/02/202506:01Edgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
19/02/202505:58Business WireBausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 GuidanceNYSE:BLCOBausch plus Lomb Corporation
06/02/202506:00Business WireBausch + Lomb Provides Update on Potential SaleNYSE:BLCOBausch plus Lomb Corporation
22/01/202506:00Business WireBausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19NYSE:BLCOBausch plus Lomb Corporation
13/01/202506:00Business WireBausch + Lomb Bolsters Pipeline with Acquisition of Whitecap BiosciencesNYSE:BLCOBausch plus Lomb Corporation
13/01/202505:00Business WireBausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European UnionNYSE:BLCOBausch plus Lomb Corporation
07/01/202506:00Business WireBausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising ChallengeNYSE:BLCOBausch plus Lomb Corporation
02/01/202506:00Business WireBausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNYSE:BLCOBausch plus Lomb Corporation
12/12/202406:00Business WireBausch + Lomb Responds to Rumors of a Potential SaleNYSE:BLCOBausch plus Lomb Corporation
11/12/202405:59Business WireBausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment CapabilitiesNYSE:BLCOBausch plus Lomb Corporation
14/11/202406:00Business WireBausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling ProgramsNYSE:BLCOBausch plus Lomb Corporation
30/10/202415:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BLCOBausch plus Lomb Corporation
30/10/202406:00Business WireBausch + Lomb Announces Third-Quarter 2024 ResultsNYSE:BLCOBausch plus Lomb Corporation
14/10/202406:00Business WireBausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular LensNYSE:BLCOBausch plus Lomb Corporation
09/10/202407:00Business WireBausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30NYSE:BLCOBausch plus Lomb Corporation
01/10/202406:00Business WireBausch + Lomb Launches Opal™ Digital Marketplace in the United StatesNYSE:BLCOBausch plus Lomb Corporation
17/09/202405:42IH Market NewsInvestors Anticipate Retail Sales Data and Fed Decision; Oil Prices Dip as Investors Weigh U.S. ProductionNYSE:BLCOBausch plus Lomb Corporation
01/08/202415:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:BLCOBausch plus Lomb Corporation
31/07/202406:00Business WireBausch + Lomb Announces Second-Quarter 2024 ResultsNYSE:BLCOBausch plus Lomb Corporation
11/07/202411:05Business WireBausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31NYSE:BLCOBausch plus Lomb Corporation
08/07/202406:00Business WireMillions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find ReliefNYSE:BLCOBausch plus Lomb Corporation
17/06/202406:00Business WireBausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 CongressNYSE:BLCOBausch plus Lomb Corporation
10/06/202406:00Business WireBausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United StatesNYSE:BLCOBausch plus Lomb Corporation
03/06/202406:00Business WireBausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United StatesNYSE:BLCOBausch plus Lomb Corporation
29/05/202415:30Business WireBausch + Lomb Announces 2024 Annual Meeting of Shareholder ResultsNYSE:BLCOBausch plus Lomb Corporation
28/05/202408:00Business WireBausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®NYSE:BLCOBausch plus Lomb Corporation
28/05/202405:59Business WireBausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular LensNYSE:BLCOBausch plus Lomb Corporation
07/05/202408:09IH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:BLCOBausch plus Lomb Corporation
06/05/202415:34IH Market NewsU.S. Stocks See Further Upside Amid Renewed Interest Rate OptimismNYSE:BLCOBausch plus Lomb Corporation
 Showing the most relevant articles for your search:NYSE:BLCO